Researcher Spotlight: David Russler-Germain, MD, PhD WASHINGTON UNIVERSITY IN ST. LOUIS Follicular lymphoma (FL) is typically a slow-growing disease with high response rates to initial therapy, but disease outcomes vary considerably from patient to patient. Dr. Russler-Germain, therefore, is researching…
Researcher Spotlight: Caitlin Gribbin, MD NEW YORK-PRESBYTERIAN/WEILL CORNELL The Kellie and Jeff Fellinge Scholar The follicular lymphoma (FL) tumor microenvironment is made up of a wide variety of non-lymphoma cells that contribute to the growth and progression of tumor cells.…
Researcher Spotlight: Matthew Klairmont, MD NEW YORK UNIVERSITY SCHOOL OF MEDICINE In many cases, follicular lymphoma (FL) is an indolent and treatable B-cell lymphoma, and most patients live a normal lifespan. However, in a subset of patients, the disease can…
Researcher Spotlight: Samuel Yamshon, MD JOAN & SANFORD I. WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY In recent years, there has been substantial research interest in harnessing the power of the body’s own immune system to help fight lymphoma. This type…
Researcher Spotlight: Hans-Guido Wendel, MD Memorial Sloan Kettering Cancer Center Mutations in epigenetic regulators of gene expression are common in follicular lymphoma (FL), which result in altered expression of hundreds of genes. Throughcollaborative efforts with clinical and research leaders at…
Researcher Spotlight: David Scott, MBCHB, PhD BC Cancer The disease course for follicular lymphoma (FL) is highly variable, and while many patients respond to treatment, some may experience relapse or evolution of disease into a more aggressive form of lymphoma.…
Researcher Spotlight: Abner Louissaint, MD, PhD Massachussetts GEneral Hospital Follicular lymphoma (FL) is unique among lymphomas in that there are many interactions between tumor cells and the healthy immune cells in their environment. Although it’s known that this communication is…
Researcher Spotlight: Todd Fehniger, MD, PhD washington university school of medicine Natural killer (NK) cells are a type of immune cell that fight infections and cancer cells. Using advanced techniques for single-cell analysis, Dr. Fehniger’s LRF research aims to study…
Researcher Spotlight: Stephen Ansell, MD, PhD mayo clinic, rochester In addition to lymphoma B cells, a variety of other immune cells are found in the lymph nodes of patients with follicular lymphoma (FL), including diverse populations of T cells. Dr.…
Researcher Spotlight: Antonio Ferreira, PHD Brigham and Women’s Hospital The tumor microenvironment, comprised of both tumor cells and healthy cells, may play a role in growth and proliferation of malignant cells. Dr. Ferreira’s LRF research, funded under the Foundation’s larger…